What are you looking for?
Need help finding what you are looking for? Contact Us

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1165558

Cover Image

PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1165558

Developments in Digital Biomanufacturing: Technology Growth Opportunities

PAGES: 65 Pages
DELIVERY TIME: 1-2 business days
Web Access (Regional License)
USD 4950

Add to Cart

Digital Technologies Driving Transformational Growth Across the Biomanufacturing Value Chain

Digitalization of the entire value chain will drive next-generation biomanufacturing. The industry is all set to move away from the traditional pen-and-paper-based process to a more advanced, digitized, track-and-trace process that is aligned toward Industry 4.0. Digital tools applied across processes, monitoring, analytics, and operations have accelerated biomanufacturing with a data-driven approach. Digital biomanufacturing can streamline processes and assist with optimal use of resources.

Scalability and reproducibility are some of the crucial challenges in biomanufacturing, especially in the production of biologics, and cell and gene therapies, or viral vector manufacturing. Digitalization is enabling a sustainable, effective, cost-efficient, time-efficient, and error-free system for biomanufacturing.

IoT, automation/robotics, AI/machine learning, Digital Twins, and Blockchain have been deployed in various digital biomanufacturing processes, thereby ensuring a seamless and uninterrupted workflow. Digitalization enables the best control and optimization of starting materials; in upstream processes, it helps with cell culture and media optimization; for downstream processes, it helps select the best strategy for purification and impurity removal. Digital tools are also making best use of the historical biomanufacturing data to improve/optimize processes. Advanced sensors and cutting-edge software collect real-time data, which offers a complete picture of the bioreactor's condition.

Advanced analytics helps users understand variations in data and predict the most suitable conditions for biomanufacturing of therapeutics. Digital tools and powerful software platforms empower scientists and engineers and help them offer better-quality, sustainable products to patients faster and at a lower cost.

The report analyzes the progress that the biomanufacturing industry has made in terms of digitalization and how the industry embraces technological advancement to lower biomanufacturing footprint and overcome the limitations of traditional methods.

Product Code: DA70

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Digital Biomanufacturing Growth
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Digital Biomanufacturing Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology

Growth Environment Analysis

  • Scope of Analysis
  • Segmentation
  • Growth Drivers
  • Growth Restraints

Assessment of Digital Biomanufacturing Technologies

  • Benefits of Deploying Digital Biomanufacturing
  • Shift Toward a Full- Fledged Digitally Equipped Biomanufacturing Unit
  • Technology Convergence for Seamless Digital Biomanufacturing
  • Digitalization Increases Bioproduct Quality and Quantity
  • Application of Digital Biomanufacturing in Developing Therapeutics
  • Blockchain
  • AI/ML
  • Digital Twin
  • Automation & Robotics
  • IoT and Cloud

Process Control/Optimization

  • Data-driven Process Control and Optimization
  • Wide Adoption of Cell Culture Automation and Optimization in Upstream Process
  • Shift Toward Continuous Biomanufacturing for Downstream Processes
  • Industry Stakeholders Optimizing Upstream and Downstream Processes for a Smooth Transformation

Process Analytics & Monitoring

  • Advanced Analytics for Biomanufacturing Data
  • Advanced Analytical System to Monitor Biomanufacturing
  • Advancements in Digital Analytical Tools for Real-Time Product Quality Check
  • New Approaches in Advanced Process Analytics
  • Predictive Approaches to Lead the Way Forward for Biomanufacturing

Factory Operations

  • Digital Solution to Enable Efficient Factory Outcomes and Operational Challenges
  • Transformation to a Full-Fledged Digital Factory Operation Systems
  • Companies Improving the Entire Manufacturing Operations Digitally
  • Collaboration between CDMOs and Biopharmas to Increase Digitization of Biomanufacturing

Supply Chain

  • Digital Solution to Improve Supply Chain
  • Digital Supply Chain Increases Transparency and Interaction
  • Blockchain Creating Safe and Well-covered Network for Supply Chain
  • The Path Ahead

Adoption and Implementation of Digital Tools

  • Encouraging Funding Activities for the Adoption of Digital Biomanufacturing
  • Collaborations for Implementation of Digital Biomanufacturing
  • Collaborations for Implementation of Digital Biomanufacturing (continued)
  • Company Categorization Based on Digital Biomanufacturing Capabilities
  • Key Takeaways

Growth Opportunity Universe

  • Growth Opportunity 1: Adoption of Digital Twins
  • Growth Opportunity 1: Adoption of Digital Twins (continued)
  • Growth Opportunity 2: Incorporation of Predictive Analytics
  • Growth Opportunity 2: Incorporation of Predictive Analytics (continued)
  • Growth Opportunity 3: Targeted Acquisitions
  • Growth Opportunity 3: Targeted Acquisitions of Digital Technology Developers by CDMOs (continued)

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • Legal Disclaimer
Have a question?

Jeroen Van Heghe

Manager - EMEA



Christine Sirois

Manager - Americas


Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!